India, Aug. 7 -- The Government of India has issued a release:
Year
No. of Misleading Advertisements received
1.
2023
7771
2.
2024
10161
3.
2025
16129
Total
34061
State/UTs
No. of Misleading Advertisements received through Ayush Suraksha Portal
Action taken thereon
1
Madhya Pradesh
1115
661
2
Odisha
447
447
3
Kerala
152
152
4
Tripura
70
68
5
Delhi
459
459
6
Tamil Nadu
3,079
3,079
7
Uttarakhand
300
300
8
Uttar Pradesh
44
44
9
Meghalaya
Nil
-
10
Goa
Nil
-
11
Haryana
Nil
-
12
Manipur
Nil
-
S. No.
S. No.
The Ministry of Ayush has been implementing the Pharmacovigilance Programme for Ayush drugs since 2018 to monitor the safety of Ayush medicines through surveillance, reporting and assessment of suspected adverse drug reactions, thereby promoting their safe and rational use. The Programme also monitors misleading advertisements relating to Ayush drugs to curb false and exaggerated claims and safeguard consumer interests. The Programme was incorporated under the Ayush Oushadhi Gunavatta Evam Uttpadan Samvardhan Yojana (AOGUSY) in 2021.The total number of complaints received by the Ministry regarding misleading advertisements related to Ayush drugs under Pharmacovigilance Program for Ayush drugs in last three years are attached at Annexure-1.
Further, Ministry of Ayush has launched an IT enabled online portal "Ayush Suraksha" to track the reported Misleading Advertisements (MLAs)/Objectionable Advertisements (OAs) and Adverse Drug Reactions (ADRs) in 2025. As per information received from State/UTs, the misleading advertisements reported on Ayush Suraksha Portal since its inception and action taken thereon are attached at Annexure-2.
As per the section 8 of Drugs & Magic Remedies (Objectionable Advertisements) Act, 1954, States and UTs are empowered to notify officers to enforce the provisions of Drugs & Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules there under. It encompasses the provisions for prohibition of misleading advertisements and exaggerated claims of drugs and medicinal substances including Ayush medicines, which appear in the print and electronic media and Ministry of Ayush has issued advisories and gives direction to SLAs to enforce and regulate as per the provision of this Act.
Further, the following actions have been taken by the Ministry to strengthen the regulatory/advisory framework to curb misleading/objectionable advertisements-
Annexure-1
Annexure-2
This information was given by Union Minister of State (I/C) for Ayush, Shri Prataprao Jadhav in a written reply in lok Sabha today.
Disclaimer: Curated by HT Syndication.
